Skip to main content

Advertisement

SpringerLink
Log in

Incidence and long-term prognosis of papillary renal cell carcinoma

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Objectives

Papillary renal cell carcinoma (pRCC) represents the largest subgroup of non-clear-cell kidney cancer. In this study, we assessed tumour characteristics and long-term prognosis of patients with pRCC in comparison with conventional clear-cell cancer (ccRCC).

Methods

We evaluated 744 patients who had undergone renal surgery for RCC between 1990 and 2005. The mean follow-up was 5.6 years, the patients being followed-up until December 2007.

Results

Both groups, pRCC and ccRCC, were alike concerning age, body mass index, and the incidence of regional lymph node or distant metastasis at diagnosis. The percentage of male patients was higher in pRCC than in ccRCC (73.8 vs. 60.3%, p = 0.006). Even though patients with pRCC presented more often with smaller (p = 0.039) and low-grade tumours (p = 0.006), there was no statistically significant difference in tumour recurrence or tumour related death. Kaplan–Meier curves revealed no differences regarding tumour specific survival between pRCC and ccRCC (p = 0.94; 5-year survival 78 vs. 77%).

Conclusions

Even though pRCC and ccRCC differ significantly in many aspects including histology and genetic alterations, their long term prognosis is comparable. As we could not confirm a favourable clinical course for pRCC in general, standardised aftercare programmes and—if necessary—systemic treatment, especially in the era of novel targeted drugs, are also needed for this common RCC subtype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, Deshpande A, Menon M (2002) Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26:281–291. doi:10.1097/00000478-200203000-00001

    Article  PubMed  Google Scholar 

  • Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624. doi:10.1097/00000478-200305000-00005

    Article  PubMed  Google Scholar 

  • Delahunt B, Eble JN (1997) Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10:537–544

    PubMed  CAS  Google Scholar 

  • Delahunt B, Bethwaite PB, Nacey JN (2007) Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 39:459–465. doi:10.1080/00313020701570061

    Article  PubMed  CAS  Google Scholar 

  • Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV (2005) Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Eur Urol 48:593–600. doi:10.1016/j.eururo.2005.04.016

    Article  PubMed  Google Scholar 

  • Herrmann E, Brinkmann OA, Bode ME, Bierer S, Kopke T, Bogemann M, Hertle L, Wulfing C (2007) Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with interleukin 2, interferon alpha and 5-fluorouracil. Eur Urol 51:1625–1631. doi:10.1016/j.eururo.2006.11.003

    Article  PubMed  CAS  Google Scholar 

  • Kim H, Cho NH, Kim DS, Kwon YM, Kim EK, Rha SH, Park YW, Shim JW, Lee SS, Lee SN, Lee J, Lee JS, Lee TJ, Jung SJ, Jung SH, Chung JH, Cho HY, Joo HJ, Choi YJ, Choi C, Han WS, Hur B, Ro JY (2004) Renal cell carcinoma in South Korea: a multicenter study. Hum Pathol 35:1556–1563. doi:10.1016/j.humpath.2004.06.011

    Article  PubMed  Google Scholar 

  • Klatte T, Patard JJ, Wunderlich H, Goel RH, Lam JS, Junker K, Schubert J, Bohm M, Allhoff EP, Kabbinavar FF, Crepel M, Cindolo L, De La Taille A, Tostain J, Mejean A, Soulie M, Bellec L, Bernhard JC, Ferriere JM, Pfister C, Albouy B, Colombel M, Zisman A, Belldegrun AS, Pantuck AJ (2007) Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. J Urol 177:2081–2086. doi:10.1016/j.juro.2007.01.122

    Article  PubMed  Google Scholar 

  • Krambeck A, Iwaszko M, Leibovich B, Cheville J, Frank I, Blute M (2008) Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery. BJU Int 101:1375–1379. doi:10.1111/j.1464-410X.2008.07588.x

    Article  PubMed  Google Scholar 

  • Lin ZH, Han EM, Lee ES, Kim CW, Kim HK, Kim I, Kim YS (2004) A distinct expression pattern and point mutation of c-kit in papillary renal cell carcinomas. Mod Pathol 17:611–616. doi:10.1038/modpathol.3800108

    Article  PubMed  CAS  Google Scholar 

  • Linehan WM, Walther MM, Zbar B (2003) The genetic basis of cancer of the kidney. J Urol 170:2163–2172. doi:10.1097/01.ju.0000096060.92397.ed

    Article  PubMed  CAS  Google Scholar 

  • Linehan WM, Vasselli J, Srinivasan R, Walther MM, Merino M, Choyke P, Vocke C, Schmidt L, Isaacs JS, Glenn G, Toro J, Zbar B, Bottaro D, Neckers L (2004) Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin Cancer Res 10:6282S–6289S. doi:10.1158/1078-0432.CCR-050013

    Article  PubMed  CAS  Google Scholar 

  • Ljungberg B, Alamdari FI, Stenling R, Roos G (1999) Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol 36:565–569. doi:10.1159/000020049

    Article  PubMed  CAS  Google Scholar 

  • Mancilla-Jimenez R, Stanley RJ, Blath RA (1976) Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases. Cancer 38:2469–2480 10.1002/1097-0142(197612)38:6<2469::AID-CNCR2820380636>3.0.CO;2-R

    Article  PubMed  CAS  Google Scholar 

  • Margulis V, Tamboli P, Matin SF, Swanson DA, Wood CG (2008) Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer 112:1480–1488. doi:10.1002/cncr.23322

    Article  PubMed  Google Scholar 

  • Mejean A, Hopirtean V, Bazin JP, Larousserie F, Benoit H, Chretien Y, Thiounn N, Dufour B (2003) Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. J Urol 170:764–767. doi:10.1097/01.ju.0000081122.57148.ec

    Article  PubMed  Google Scholar 

  • Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ (2000) Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 89:604–614 10.1002/1097-0142(20000801)89:3<604::AID-CNCR16>3.0.CO;2-Q

    Article  PubMed  CAS  Google Scholar 

  • Motzer RJ, Bacik J, Mariani T, Russo P, Mazumdar M, Reuter V (2002) Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 20:2376–2381. doi:10.1200/JCO.2002.11.123

    Article  PubMed  Google Scholar 

  • Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Guille F, Chopin DK, Mulders PF, Wood CG, Swanson DA, Figlin RA, Belldegrun AS, Pantuck AJ (2005) Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23:2763–2771. doi:10.1200/JCO.2005.07.055

    Article  PubMed  Google Scholar 

  • Pignot G, Elie C, Conquy S, Vieillefond A, Flam T, Zerbib M, Debre B, Amsellem-Ouazana D (2007) Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 69:230–235. doi:10.1016/j.urology.2006.09.052

    Article  PubMed  Google Scholar 

  • Ronnen EA, Kondagunta GV, Ishill N, Spodek L, Russo P, Reuter V, Bacik J, Motzer RJ (2006) Treatment outcome for metastatic papillary renal cell carcinoma patients. Cancer 107:2617–2621. doi:10.1002/cncr.22340

    Article  PubMed  CAS  Google Scholar 

  • Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJ, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Storkel S, Lerman MI, Linehan WM, Zbar B (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68–73. doi:10.1038/ng0597-68

    Article  PubMed  CAS  Google Scholar 

  • Schrader AJ, Varga Z, Hegele A, Pfoertner S, Olbert P, Hofmann R (2006a) Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches. J Cancer Res Clin Oncol 132:137–149. doi:10.1007/s00432-005-0058-4

    Article  PubMed  CAS  Google Scholar 

  • Schrader AJ, Varga Z, Pfoertner S, Goelden U, Buer J, Hofmann R (2006b) Treatment targeted at vascular endothelial growth factor: a promising approach to managing metastatic kidney cancer. BJU Int 97:461–465. doi:10.1111/j.1464-410X.2006.05873.x

    Article  PubMed  CAS  Google Scholar 

  • Schrader AJ, Olbert PJ, Hegele A, Varga Z, Hofmann R (2008) Metastatic non-clear cell renal cell carcinoma: current therapeutic options. BJU Int 30:1343–1345. doi:10.1111/j.1464-410X.2008.07462.x

    Article  Google Scholar 

  • Steiner T, Roigas J, Kirchner H, Doehn C, Heynemann H, Siebels M, Loening S, Jocham D, Fornara P, Rohde D, Stieff C (2006) Clinical course of patients with metastatic papillary renal cell carcinoma. J Clin Oncol 24 (Abstract 14591)

  • Storkel S, Eble JN, Adlakha K, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K (1997) Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:987–989 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2

    Article  PubMed  CAS  Google Scholar 

  • Sweeney P, El-Naggar AK, Lin SH, Pisters LL (2002) Biological significance of c-met over expression in papillary renal cell carcinoma. J Urol 168:51–55. doi:10.1016/S0022-5347(05)64830-6

    Article  PubMed  CAS  Google Scholar 

  • Wunderlich H, Schlichter A, Zermann D, Reichelt O, Kosmehl H, Schubert J (1999) Multifocality in renal cell carcinoma: a bilateral event? Urol Int 63:160–163. doi:10.1159/000030439

    Article  PubMed  CAS  Google Scholar 

  • Yang XJ, Tan MH, Kim HL, Ditlev JA, Betten MW, Png CE, Kort EJ, Futami K, Furge KA, Takahashi M, Kanayama HO, Tan PH, Teh BS, Luan C, Wang K, Pins M, Tretiakova M, Anema J, Kahnoski R, Nicol T, Stadler W, Vogelzang NG, Amato R, Seligson D, Figlin R, Belldegrun A, Rogers CG, Teh BT (2005) A molecular classification of papillary renal cell carcinoma. Cancer Res 65:5628–5637. doi:10.1158/0008-5472.CAN-05-0533

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Philipps-University Medical School, Baldingerstrasse 1, 35043, Marburg, Germany

    A. J. Schrader, S. Rauer-Bruening, P. J. Olbert, A. Hegele, J. Rustemeier, Z. Varga & R. Hofmann

  2. Institute for Medical Biometry and Epidemiology, Philipps-University Medical School, Bunsenstrasse 3, 35037, Marburg, Germany

    N. Timmesfeld

Authors
  1. A. J. Schrader
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Rauer-Bruening
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. J. Olbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Hegele
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Rustemeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. Timmesfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Z. Varga
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Hofmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. J. Schrader.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schrader, A.J., Rauer-Bruening, S., Olbert, P.J. et al. Incidence and long-term prognosis of papillary renal cell carcinoma. J Cancer Res Clin Oncol 135, 799–805 (2009). https://doi.org/10.1007/s00432-008-0515-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-008-0515-y

Keywords

Search

Navigation